Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
U S Stem Cell Inc's Business Segments
U S Stem Cell Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
-
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/USRM/segments
https://api.csimarket.com/api/v1/companies/USRM/geographic
https://api.csimarket.com/api/v1/companies/USRM/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
Annual Results
Revenue by Product & Service Category -
- Product81.7%
- Service19.5%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 0 | 81.7% |
| Service | $ 0 | 19.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of U S Stem Cell Inc
U.S. Stem Cell Inc. is a biotechnology company headquartered in Sunrise, Florida, United States. The company specializes in the development of novel cell-based therapies for various medical conditions and diseases. Its focus is on utilizing stem cells derived from the body's own adipose tissue and manipulating them to treat conditions such as osteoarthritis, autoimmune diseases, and cardiovascular diseases.
The company's flagship product is called AdipocellTM, which is an autologous cell therapy designed to treat orthopedic conditions. AdipocellTM involves harvesting adipose tissue from the patient, isolating and processing the stem cells present in the tissue, and then injecting them back into the affected area. This treatment aims to improve joint functionality, reduce pain, and promote tissue regeneration.
U.S. Stem Cell Inc. operates state-of-the-art medical facilities known as Cell Surgical Network® clinics, where these innovative therapies are administered. The company has established a network of licensed clinics across the United States, allowing patients to access these regenerative treatments conveniently.
In addition to its focus on orthopedic conditions, U.S. Stem Cell Inc. also conducts research and development efforts in other therapeutic areas. The company is actively involved in exploring stem cell-based treatments for autoimmune diseases such as multiple sclerosis, lupus, and Crohn's disease. It also investigates the potential of stem cells in addressing cardiovascular diseases like heart failure and peripheral artery disease.
The company's research and development efforts are supported by a team of skilled scientists and medical professionals who possess extensive knowledge in stem cell biology and regenerative medicine. U.S. Stem Cell Inc. collaborates with renowned academic institutions and medical centers to advance its research goals and stay at the forefront of the field.
Furthermore, U.S. Stem Cell Inc. is committed to maintaining high-quality standards and ensuring patient safety. The company strictly follows FDA guidelines and regulations for cell-based therapies. It adheres to rigorous manufacturing and quality control procedures to ensure the safety and efficacy of its products.
Overall, U.S. Stem Cell Inc. is a leading player in the field of regenerative medicine, with a focus on utilizing stem cells for treating various medical conditions. The company's innovative therapies, research efforts, and commitment to patient safety position it as a significant contributor to advancing the field of regenerative medicine in the United States.
The company's flagship product is called AdipocellTM, which is an autologous cell therapy designed to treat orthopedic conditions. AdipocellTM involves harvesting adipose tissue from the patient, isolating and processing the stem cells present in the tissue, and then injecting them back into the affected area. This treatment aims to improve joint functionality, reduce pain, and promote tissue regeneration.
U.S. Stem Cell Inc. operates state-of-the-art medical facilities known as Cell Surgical Network® clinics, where these innovative therapies are administered. The company has established a network of licensed clinics across the United States, allowing patients to access these regenerative treatments conveniently.
In addition to its focus on orthopedic conditions, U.S. Stem Cell Inc. also conducts research and development efforts in other therapeutic areas. The company is actively involved in exploring stem cell-based treatments for autoimmune diseases such as multiple sclerosis, lupus, and Crohn's disease. It also investigates the potential of stem cells in addressing cardiovascular diseases like heart failure and peripheral artery disease.
The company's research and development efforts are supported by a team of skilled scientists and medical professionals who possess extensive knowledge in stem cell biology and regenerative medicine. U.S. Stem Cell Inc. collaborates with renowned academic institutions and medical centers to advance its research goals and stay at the forefront of the field.
Furthermore, U.S. Stem Cell Inc. is committed to maintaining high-quality standards and ensuring patient safety. The company strictly follows FDA guidelines and regulations for cell-based therapies. It adheres to rigorous manufacturing and quality control procedures to ensure the safety and efficacy of its products.
Overall, U.S. Stem Cell Inc. is a leading player in the field of regenerative medicine, with a focus on utilizing stem cells for treating various medical conditions. The company's innovative therapies, research efforts, and commitment to patient safety position it as a significant contributor to advancing the field of regenerative medicine in the United States.
U.S. Stem Cell Inc. is a biotechnology company that primarily focuses on the development and commercialization of stem cell therapies and regenerative medicine products. The segments, products, and services offered by the company can be categorized as follows:
1. Stem Cell Therapy
- Autologous Cell Therapy: U.S. Stem Cell offers treatments derived from the patients own stem cells. This includes processes to isolate, culture, and reinfuse the cells to promote healing and regeneration in various conditions.
- Allogeneic Cell Therapy: The company also explores the use of stem cells derived from donors to treat patients, which can offer broader applications in disease management.
Research and Development
- U.S. Stem Cell invests significantly in R&D to innovate stem cell therapies. This includes preclinical and clinical research aimed at treating conditions such as:
- Orthopedic disorders (e.g. osteoarthritis, cartilage damage)
- Cardiovascular diseases
- Neurodegenerative disorders (e.g. Parkinson’s disease)
- Autoimmune diseases
- Wound healing and skin regeneration
- This segment may involve collaborations with research institutions and universities to enhance knowledge and technology related to stem cells.
Manufacturing and Processing
- The company provides services related to the extraction, processing, and storage of stem cells. This includes:
- Cell Processing Facilities: U.S. Stem Cell operates state-of-the-art facilities to ensure the safe and effective processing of stem cells.
- Quality Control: They maintain rigorous quality assurance protocols to guarantee the efficacy and safety of their products.
Regulatory Compliance and Support
- U.S. Stem Cell assists clients in navigating the complex regulatory landscape surrounding stem cell therapies. This service may include:
- Guidance on FDA requirements for clinical trials.
- Assistance in the submission of IND (Investigational New Drug) applications.
- Ongoing support during the regulatory review process to facilitate faster approvals.
Consultative and Educational Services
- The company provides consultative services for healthcare providers, helping them integrate stem cell therapies into their practice. This includes:
- Training programs for medical professionals on stem cell utilization.
- Educational seminars and workshops about the latest advancements in regenerative medicine.
- Development of treatment protocols and product usage guidelines to ensure patient safety and optimal outcomes.
Product Offerings
- Stem Cell Products: U.S. Stem Cell develops a range of proprietary stem cell products for various applications. These can include:
- Regenerative Products: Formulated for use in clinical settings to promote healing and cellular regeneration.
- Cosmetic and Aesthetic Applications: Introducing products that utilize stem cells for skin rejuvenation and anti-aging treatments.
Clinical Programs
- U.S. Stem Cell engages in several active clinical trials and programs aimed at evaluating the safety and effectiveness of new stem cell therapies. They often publish findings and collaborate with medical institutions to enhance treatment methodologies.
8. Customer Support and Follow-Up
- The company emphasizes the importance of patient care, providing follow-up services and support to monitor outcomes and address any concerns related to stem cell treatments. This is integral to refining their offerings and enhancing patient satisfaction.
Conclusion
U.S. Stem Cell Inc. maintains a robust portfolio that includes various therapies, R&D, manufacturing services, regulatory support, educational offerings, and clinical programs focused on advancing the field of regenerative medicine. The companys comprehensive approach demonstrates their commitment to innovation and excellence in the burgeoning area of stem cell therapies.
1. Stem Cell Therapy
- Autologous Cell Therapy: U.S. Stem Cell offers treatments derived from the patients own stem cells. This includes processes to isolate, culture, and reinfuse the cells to promote healing and regeneration in various conditions.
- Allogeneic Cell Therapy: The company also explores the use of stem cells derived from donors to treat patients, which can offer broader applications in disease management.
Research and Development
- U.S. Stem Cell invests significantly in R&D to innovate stem cell therapies. This includes preclinical and clinical research aimed at treating conditions such as:
- Orthopedic disorders (e.g. osteoarthritis, cartilage damage)
- Cardiovascular diseases
- Neurodegenerative disorders (e.g. Parkinson’s disease)
- Autoimmune diseases
- Wound healing and skin regeneration
- This segment may involve collaborations with research institutions and universities to enhance knowledge and technology related to stem cells.
Manufacturing and Processing
- The company provides services related to the extraction, processing, and storage of stem cells. This includes:
- Cell Processing Facilities: U.S. Stem Cell operates state-of-the-art facilities to ensure the safe and effective processing of stem cells.
- Quality Control: They maintain rigorous quality assurance protocols to guarantee the efficacy and safety of their products.
Regulatory Compliance and Support
- U.S. Stem Cell assists clients in navigating the complex regulatory landscape surrounding stem cell therapies. This service may include:
- Guidance on FDA requirements for clinical trials.
- Assistance in the submission of IND (Investigational New Drug) applications.
- Ongoing support during the regulatory review process to facilitate faster approvals.
Consultative and Educational Services
- The company provides consultative services for healthcare providers, helping them integrate stem cell therapies into their practice. This includes:
- Training programs for medical professionals on stem cell utilization.
- Educational seminars and workshops about the latest advancements in regenerative medicine.
- Development of treatment protocols and product usage guidelines to ensure patient safety and optimal outcomes.
Product Offerings
- Stem Cell Products: U.S. Stem Cell develops a range of proprietary stem cell products for various applications. These can include:
- Regenerative Products: Formulated for use in clinical settings to promote healing and cellular regeneration.
- Cosmetic and Aesthetic Applications: Introducing products that utilize stem cells for skin rejuvenation and anti-aging treatments.
Clinical Programs
- U.S. Stem Cell engages in several active clinical trials and programs aimed at evaluating the safety and effectiveness of new stem cell therapies. They often publish findings and collaborate with medical institutions to enhance treatment methodologies.
8. Customer Support and Follow-Up
- The company emphasizes the importance of patient care, providing follow-up services and support to monitor outcomes and address any concerns related to stem cell treatments. This is integral to refining their offerings and enhancing patient satisfaction.
Conclusion
U.S. Stem Cell Inc. maintains a robust portfolio that includes various therapies, R&D, manufacturing services, regulatory support, educational offerings, and clinical programs focused on advancing the field of regenerative medicine. The companys comprehensive approach demonstrates their commitment to innovation and excellence in the burgeoning area of stem cell therapies.